Home Interviews BioStock Investor Pitch: Spermosens

BioStock Investor Pitch: Spermosens

16 January, 2023

BioStock Investor Pitch: Spermosens

16 January, 2023

Swedish Spermosens’ vision is to improve diagnostics within the area of male infertility and thus help improve IVF treatments. Using the company’s JUNO-Checked system the sperm’s ability to bond to the egg cell can be tested and the result can help clinicians determine the best treatment course making IVF-treatments more efficient. CEO Ulrik Nilsson visited BioStock’s studio to present the company, its product, and the development plan.

Watch Spermosens’ CEO Ulrik Nilsson present the company below.

The content of BioStock’s news and analyses is independent but the work of BioStock is to a certain degree financed by life science companies. The above article concerns a company from which BioStock has received financing.